» Articles » PMID: 25769672

Perspective: a Dynamics-based Classification of Ventricular Arrhythmias

Overview
Date 2015 Mar 15
PMID 25769672
Citations 38
Authors
Affiliations
Soon will be listed here.
Abstract

Despite key advances in the clinical management of life-threatening ventricular arrhythmias, culminating with the development of implantable cardioverter-defibrillators and catheter ablation techniques, pharmacologic/biologic therapeutics have lagged behind. The fundamental issue is that biological targets are molecular factors. Diseases, however, represent emergent properties at the scale of the organism that result from dynamic interactions between multiple constantly changing molecular factors. For a pharmacologic/biologic therapy to be effective, it must target the dynamic processes that underlie the disease. Here we propose a classification of ventricular arrhythmias that is based on our current understanding of the dynamics occurring at the subcellular, cellular, tissue and organism scales, which cause arrhythmias by simultaneously generating arrhythmia triggers and exacerbating tissue vulnerability. The goal is to create a framework that systematically links these key dynamic factors together with fixed factors (structural and electrophysiological heterogeneity) synergistically promoting electrical dispersion and increased arrhythmia risk to molecular factors that can serve as biological targets. We classify ventricular arrhythmias into three primary dynamic categories related generally to unstable Ca cycling, reduced repolarization, and excess repolarization, respectively. The clinical syndromes, arrhythmia mechanisms, dynamic factors and what is known about their molecular counterparts are discussed. Based on this framework, we propose a computational-experimental strategy for exploring the links between molecular factors, fixed factors and dynamic factors that underlie life-threatening ventricular arrhythmias. The ultimate objective is to facilitate drug development by creating an in silico platform to evaluate and predict comprehensively how molecular interventions affect not only a single targeted arrhythmia, but all primary arrhythmia dynamics categories as well as normal cardiac excitation-contraction coupling.

Citing Articles

Mechanistic Insights into Melatonin's Antiarrhythmic Effects in Acute Ischemia-Reperfusion-Injured Rabbit Hearts Undergoing Therapeutic Hypothermia.

Lee H, Chang P, Wo H, Chou S, Chou C Int J Mol Sci. 2025; 26(2).

PMID: 39859328 PMC: 11766167. DOI: 10.3390/ijms26020615.


Small extracellular vesicles derived from umbilical cord mesenchymal stem cells alleviate radiation-induced cardiac organoid injury.

Cao H, Yue L, Shao J, Kong F, Liu S, Huai H Stem Cell Res Ther. 2024; 15(1):493.

PMID: 39707562 PMC: 11662859. DOI: 10.1186/s13287-024-04115-2.


Study on the mechanisms and Pharmacodynamic substances of Lian-Gui-Ning-Xin-Tang on Arrhythmia Therapy based on Pharmacodynamic-Pharmacokinetic associations.

Jiayu L, Xiaofeng L, Jinhong C, Fangjun D, Boya F, Xin Z Heliyon. 2024; 10(16):e36104.

PMID: 39253118 PMC: 11381611. DOI: 10.1016/j.heliyon.2024.e36104.


Cell-to-cell heterogeneity in ion channel conductance impacts substrate vulnerability to arrhythmia.

Pullinger T, Sobie E Am J Physiol Heart Circ Physiol. 2024; 327(1):H242-H254.

PMID: 38758124 PMC: 11381019. DOI: 10.1152/ajpheart.00645.2023.


Timing mechanisms to control heart rhythm and initiate arrhythmias: roles for intracellular organelles, signalling pathways and subsarcolemmal Ca.

Terrar D Philos Trans R Soc Lond B Biol Sci. 2023; 378(1879):20220170.

PMID: 37122228 PMC: 10150226. DOI: 10.1098/rstb.2022.0170.


References
1.
Bassani J, Yuan W, Bers D . Fractional SR Ca release is regulated by trigger Ca and SR Ca content in cardiac myocytes. Am J Physiol. 1995; 268(5 Pt 1):C1313-9. DOI: 10.1152/ajpcell.1995.268.5.C1313. View

2.
Shilnikov A, Cymbalyuk G . Transition between tonic spiking and bursting in a neuron model via the blue-sky catastrophe. Phys Rev Lett. 2005; 94(4):048101. DOI: 10.1103/PhysRevLett.94.048101. View

3.
Karma . Spiral breakup in model equations of action potential propagation in cardiac tissue. Phys Rev Lett. 1993; 71(7):1103-1106. DOI: 10.1103/PhysRevLett.71.1103. View

4.
Cerrone M, Noujaim S, Tolkacheva E, Talkachou A, OConnell R, Berenfeld O . Arrhythmogenic mechanisms in a mouse model of catecholaminergic polymorphic ventricular tachycardia. Circ Res. 2007; 101(10):1039-48. PMC: 2515360. DOI: 10.1161/CIRCRESAHA.107.148064. View

5.
Qu Z, Nivala M, Weiss J . Calcium alternans in cardiac myocytes: order from disorder. J Mol Cell Cardiol. 2012; 58:100-9. PMC: 3570622. DOI: 10.1016/j.yjmcc.2012.10.007. View